Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR sell Snowman

Start price
€148.75
30.01.22 / 50%
Target price
€110.00
30.01.23
Performance (%)
-13.01%
End price
€129.40
31.01.23
Summary
This prediction ended on 31.01.23 with a price of €129.40. The price of BioNTech SE ADR decreased from the start of the prediction. Compared to the start price this resulted in a performance of -13.01%. Snowman has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioNTech SE ADR 7.896% 7.896% 243.124%
iShares Core DAX® -3.935% -2.628% 10.013%
iShares Nasdaq 100 -3.608% -9.283% 20.668%
iShares Nikkei 225® -4.513% -6.951% 5.241%
iShares S&P 500 -2.607% -4.402% 20.177%

According to Snowman what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Innovative
Some uniques
Top 10 in its market
Known brand
Cons
overvalued
Below average Management
High risks for its business
Probably not worthwhile Investment
Very high cyclical dependencies
Business model of the past or high risk

Comments by Snowman for this prediction

In the thread Biontech SE diskutieren
Prediction Sell
Perf. (%) -13.01%
Target price 110.000
Change
Ends at

Sell mit Kursziel 110,0

In the thread Trading Biontech SE
Prediction Sell
Perf. (%) -13.01%
Target price 110.000
Change
Ends at 30.01.23

Die von Snowman gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Snowman for BioNTech SE ADR

BioNTech SE ADR

Start price
Target price
Perf. (%)
€96.62
05.05.23
€70.00
05.05.24
-11.15%
06.05.24

Innovative
Some uniques
overvalued
Below average Management
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€204.60
09.11.21
€260.00
09.11.22
-27.30%
30.01.22

Innovative
Some uniques
overvalued
Below average Management
BioNTech SE ADR

Start price
Target price
Perf. (%)
€85.51
18.12.20
€40.00
18.12.21
14.23%
09.02.21

Innovative
Some uniques
overvalued
Below average Management